0 items USD 0.00Search
Your search for "current partnering option evaluation partnering terms agreements pharma biotech" gave back 1333440 results.
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
The “Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
February 2023
Price: USD 3,660.00
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
Market Analysis and Insights: Global Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory Market The global Pharma and Biotech...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Highlights The global Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
Catalog:
La Merie Publishing
March 2015
Price: USD 2,183.00
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Cervical Cancer - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical...
Catalog:
Global Markets Direct
May 2020
Price: USD 2,500.00
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,500.00
Cervical Cancer - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities The field of oncolytic viruses...
Catalog:
La Merie Publishing
January 2017
Price: USD 2,400.00
Cervical Cancer - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Medulloblastoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
December 2021
Price: USD 2,000.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
